These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 29683554)

  • 1. Monitoring circulating prostate cancer cells by in vivo flow cytometry assesses androgen deprivation therapy on metastasis.
    Pang K; Xie C; Yang Z; Suo Y; Zhu X; Wei D; Weng X; Wei X; Gu Z
    Cytometry A; 2018 May; 93(5):517-524. PubMed ID: 29683554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-time monitoring of rare circulating hepatocellular carcinoma cells in an orthotopic model by in vivo flow cytometry assesses resection on metastasis.
    Fan ZC; Yan J; Liu GD; Tan XY; Weng XF; Wu WZ; Zhou J; Wei XB
    Cancer Res; 2012 May; 72(10):2683-91. PubMed ID: 22454286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating tumor cells as a predictive biomarker in patients with hormone-sensitive prostate cancer.
    Goodman OB; Symanowski JT; Loudyi A; Fink LM; Ward DC; Vogelzang NJ
    Clin Genitourin Cancer; 2011 Sep; 9(1):31-8. PubMed ID: 21705286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proportion of circulating tumor cell clusters increases during cancer metastasis.
    Suo Y; Xie C; Zhu X; Fan Z; Yang Z; He H; Wei X
    Cytometry A; 2017 Mar; 91(3):250-253. PubMed ID: 28009470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating Tumor Cells as a Marker for Progression-free Survival in Metastatic Castration-naïve Prostate Cancer.
    Josefsson A; Linder A; Flondell Site D; Canesin G; Stiehm A; Anand A; Bjartell A; Damber JE; Welén K
    Prostate; 2017 Jun; 77(8):849-858. PubMed ID: 28295408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-cadherin increases after androgen deprivation and is associated with metastasis in prostate cancer.
    Jennbacken K; Tesan T; Wang W; Gustavsson H; Damber JE; Welén K
    Endocr Relat Cancer; 2010 Jun; 17(2):469-79. PubMed ID: 20233707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential establishment of lung metastatic xenograft model of androgen receptor-positive and androgen-independent prostate cancer (C4-2B).
    Yamamichi F; Matsuoka T; Shigemura K; Kawabata M; Shirakawa T; Fujisawa M
    Urology; 2012 Oct; 80(4):951.e1-7. PubMed ID: 22920407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of Prostate Cancer Patient Derived Xenograft Models from Circulating Tumor Cells.
    Williams ES; Rodriguez-Bravo V; Chippada-Venkata U; De Ia Iglesia-Vicente J; Gong Y; Galsky M; Oh W; Cordon-Cardo C; Domingo-Domenech J
    J Vis Exp; 2015 Oct; (105):53182. PubMed ID: 26555435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic CTC phenotypes in metastatic prostate cancer models visualized using magnetic ranking cytometry.
    Kermanshah L; Poudineh M; Ahmed S; Nguyen LNM; Srikant S; Makonnen R; Pena Cantu F; Corrigan M; Kelley SO
    Lab Chip; 2018 Jul; 18(14):2055-2064. PubMed ID: 29923581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Novel Association of Circulating Tumor Cells and Circulating Megakaryocytes with Prostate Cancer Prognosis.
    Xu L; Mao X; Guo T; Chan PY; Shaw G; Hines J; Stankiewicz E; Wang Y; Oliver RTD; Ahmad AS; Berney D; Shamash J; Lu YJ
    Clin Cancer Res; 2017 Sep; 23(17):5112-5122. PubMed ID: 28615267
    [No Abstract]   [Full Text] [Related]  

  • 11. Decreased adhesiveness, resistance to anoikis and suppression of GRP94 are integral to the survival of circulating tumor cells in prostate cancer.
    Howard EW; Leung SC; Yuen HF; Chua CW; Lee DT; Chan KW; Wang X; Wong YC
    Clin Exp Metastasis; 2008; 25(5):497-508. PubMed ID: 18340425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo flow cytometry: a new method for enumerating circulating cancer cells.
    Georgakoudi I; Solban N; Novak J; Rice WL; Wei X; Hasan T; Lin CP
    Cancer Res; 2004 Aug; 64(15):5044-7. PubMed ID: 15289300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating human prostate cancer cells from an orthotopic mouse model rapidly captured by immunomagnetic beads and imaged by GFP expression.
    Kolostova K; Pinterova D; Hoffman RM; Bobek V
    Anticancer Res; 2011 May; 31(5):1535-9. PubMed ID: 21617207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative characterization of androgen receptor protein expression and cellular localization in circulating tumor cells from patients with metastatic castration-resistant prostate cancer.
    Reyes EE; VanderWeele DJ; Isikbay M; Duggan R; Campanile A; Stadler WM; Vander Griend DJ; Szmulewitz RZ
    J Transl Med; 2014 Nov; 12():313. PubMed ID: 25424879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.
    Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL
    Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer.
    Okegawa T; Nutahara K; Higashihara E
    J Urol; 2008 Oct; 180(4):1342-7. PubMed ID: 18707699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of metastasis of circulating human prostate cancer cells in the chick embryo by an extracellular matrix produced by foreskin fibroblasts in culture.
    Menen R; Pinney E; Hassanein MK; Kolostova K; Bobek V; Suetsugu A; Zhang N; Bouvet M; Naughton GK; Hoffman RM
    Anticancer Res; 2012 May; 32(5):1573-7. PubMed ID: 22593434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring circulating tumor cells in vivo by a confocal microscopy system.
    Hu Y; Tang W; Cheng P; Zhou Q; Tian X; Wei X; He H
    Cytometry A; 2019 Jun; 95(6):657-663. PubMed ID: 30556307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial cell adhesion molecule-positive circulating tumor cells as predictive biomarker in patients with prostate cancer.
    Amato RJ; Melnikova V; Zhang Y; Liu W; Saxena S; Shah PK; Jensen BT; Torres KE; Davis DW
    Urology; 2013 Jun; 81(6):1303-7. PubMed ID: 23622774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlation between the expression of Pim-1 and androgen-deprivation therapy for prostate cancer].
    Wang J; Quan CY; Chang WL; Shang ZQ; Jiang N; Li B; Niu YJ
    Zhonghua Nan Ke Xue; 2015 Sep; 21(9):775-81. PubMed ID: 26552208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.